Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
43
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Platelet-activating Factor and Normal or Leukaemic Haematopoiesis

Yves Denizot UMR CNRS 6101, Faculté de Médecine, 2 rue Dr Marcland, 87025, Limoges, France
,
Laurence Guglielmi UMR CNRS 6101, Faculté de Médecine, 2 rue Dr Marcland, 87025, Limoges, France
,
Magali Donnard Laboratoire d'Hématologie, CHU Dupuytren, 2 Avenue M. Luther King, 87042, Limoges, France
&
Franck Trimoreau Laboratoire d'Hématologie, CHU Dupuytren, 2 Avenue M. Luther King, 87042, Limoges, France
Pages 775-782 | Published online: 01 Jul 2009

  • Samuelsson, B., Dahlen, S.E., Undgren, J.A., Rouzer, C.A. andSerhan, C.N. (1987) "Leukotrienes and lipoxins: structures.biosynthesis and biological effects", Science 237, 1171 -1176.
  • Wallace, J.L. (1990) "Lipid mediators of inflammation in gastriculcer", American Journal of Physiology 258. G1-G11.
  • Gentile, P., Byer. D. and Pelus. L.,VI. (1983) "In vivo modulation ofmurine myelopoiesis following intravenous administration ofprostaglandin E2", Blood 62, 1100-1107.
  • Behrens, T.W., Lum, UG., Lianos. E.A. and Goodwin. J.S. (1989)"Lipoxygenase inhibitors enhance the proliferation of human Bcells", Journal of Immunology 143, 2285-2294.
  • CIaesson, H.E., Odlander, B. and Jakohsson, P.J. (1992)"Leukotriene B4 in the immune system", International Journal oflmmunopharmacology 14, 441-449.
  • Kurland, J. and Moore. M.A.S. (1977) "Modulation of hemopoiesisby proslaglandins", Experimental Hematalogy 5, 357-373.
  • Williams, N. (1979) "Preferential inhibition of murine macrophagecolony formation by prostaglandin b", Blood 53, 1089-1094.
  • Rossi, G.B., Migliaccio, A.R., Migliaccio, G., Unicri, F., Di Rosa. M., Mastroberardino, G and Peschle. C. (1980) "In vitro interactions of PGE and cAMP with murine and human erythroid precursors", Blood 56, 74-79.
  • Slenke, L., Mansour, M., Reizenstein, P. and Lindgren, J.A. (1993) "Stimulation of human myelopoiesis by leukotricnes B4 and CA: interactions with granulocyte-macrophage colony-stimulating factor", Blood 81, 152 356.'
  • Benveniste, J., Henson. P.M. and Cochrane. CG (1972) "Lekocytcdependent histamine release from rabbit platelets: the role of IgH. basophils and a platelet-activating factor", Journal of Experimental Medicine 136, 1356-1377.
  • Snyder, F. (1994) "Metabolic processing of PAK', Clinical Review in Allergy 12, 309-327.
  • Snyder, F. (1995) "Platelet-activating factor: the biosynthetic and catabolic enzymes", Biochemical Journal 305, 689-705.
  • Venable, ME., Zimmerman. G.A., Mclntyre. T.M. and Prescott, S.M. (1993) "Platelet-activating factor: a phospholipid autacoid with diverse actions", Journal of Lipid Research 34. 691 702.
  • Benveniste, J., C'hignard. M., 1-c Couedic. J.P. and Vargaflig. B.B. (1982) "Biosynthesis of platelet-activating factor (paf-acether). II. Involvement of phospholipa.se Ai in the formation of paf-acether and lyso-paf-acelher from rabbit platelets", Thrombosis Research 25, 375-385.
  • Sisson, J.H., Prescolt. S.M., Mclntyre, T.M. and Zimmerraan, G.A. (1987) "Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events and leukotriene B4 metabolism", Journal of Immunology 138, 3918-3926.
  • Bussolino, K, Sironi. M., Bocchietlo. E. and Mantovani, A. (1992) "Synthesis of platelet-activating factor by polymorphonuclcar ncutrophils stimulated with inlcrleukin-8", Journal of Biological Chemistry 267, 14598-14603.
  • Ojima-Uchiyama, A., Masuzawa. Y., Sugiura. T., Waku. K., Fukuda T.and Makino.S. (1991) "Production of platelet-activating factor by human nonnodense and hypodense eosinophils", Lipids 26, 1200-1203.
  • Amoux, B., Jouvin-Marche, E., Amoux. A. and Benvenisle, J. (1982) "Release of PAF-acether from human blood monocytes", Agents and Actions 12, 713 -716.
  • Elstad, M.R., Prescott, S.M., Mclntyre. T.M. and Zimmerman, G.A. (1988) "Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes", Journal of Immunology 140, 1618-1624.
  • Michel, I., Denizot. Y. Thomas. Y, Jean-louis, F., Ileslan. M., Benveniste. J. and Eubettrel. L. (1990) "Production of paf-acether by human epidermal cells", Journal of Investigative Dermatology 95.576-581.
  • Michel. 1.,. Denizot, Y., Thomas. Y. Jean-Louis, F., Pitton, C., Benveniste, J. and Dubenret, L. (1988) "Biosynthesis of paf-acether by human skin fibroblasls m film", Journal of Immimology 141, 948 953.
  • Hirafuji, M., Mencia-Huerta. J.M. and Benveniste. J. (1987) "Regulation of PAF-acethcr (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin", Biochimica el Biophysica Acta 930. 359-369.
  • Pinzani, M., Carloni. V., Marra, F., Riccardi. L)., Laffi. G. and Gentilini. P. (1994) "Biosynthesis of platelet-activating factor and its 1-0-acyl analogue by liver fat-storing cells", Gastroentemloay 106, 1301-1311.
  • Ferraris, 1-., Karmeli, K. Eliakim. R., Klein, J., Fiocchi. C. and Rachmilewitz. D. (1993) "Intestinal epithelial cells contribute to the enhanced generation of platelet-activating factor in ulcerative colitis", Gut 34, 665-668.
  • Valone, F.H. and Epstein. L.H. (1988) "Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-I â, tumor necrosis factor, or INF-?", Journal of Immunology 141. 3945-3950.
  • Bussoliuo, F., Camussi, G. and Baglioni, C. (1988) "Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin lot", Journal of Biological Chcmistiy 263, 11856-11861.
  • Camussi. G., Bussolino. F., Salvidio. G. and Baglioni. C. (1987) "Tumor necrosis factor/cachectin stimulates peritoneal, macrophages, polymorpbonuclear neutrophils. and vascular endothelialcells to synthesize and release platelet-activating factor", Journal of Experimental Medicine 166, 1190-1404.
  • Wirthmueller, L., De Week. A.L. and Dahinden, CA. (1989) "Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony stimulating factor and the cheuiotactic factors C5a or forniyl-tnethionyl-leucyl-phenylalanine", Journal of Immunology 142, 3213-3218.
  • Van Der Bruggen, T., Kok, P.T.M., Raaijmakers. J A.M., Lammers. J.W.J. and Koendennan. L. (1994) "Cooperation between Fc-y receptor II and complement receptor type 3 during activation of platelet-activating factor release by cytokimr-primed human eosinophils", Journal of Immunology 153, 2729-2735.
  • Triggiani. M., Schleimer, R.P., Tomioka. K., Hubhard. W.C. and Chilton, F.H. (1992) "Characterization of platelet-activating factor synthesized by normal and granulocyte-macrophage colonystimulating factor-primed human eosinophils", Immunology 77, 500-504.
  • Dubois, C., Bissonnette. E. and Rola-Pleszczynski, M. (1989) "Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors", Journal of Immunology 143. 964-970.
  • Pignol, B., Maisonnet. T., Guinot. P., Meucia-Huerta. J.M. and Braquet, P. (1994) "Effect of platelet-activating factor on in vitro and in vivo interIeukin-6 production", Mediators of Inflammation 3. 281-285.
  • Rola-Pleszezynski, M. (1990) "Priming of human monocytes with PAF augments their production of tumor necrosis factor", Journal of Lipid Mediators 2. S77-S82.
  • Smith, C.S., Parker. L. and Shearer, WT. (1994) "Cytokine regulation by platelet-activating factor in a human B cell line", Journal oj Immunology 153, 3997-4005.
  • Ruls, N.M., Rose, J.K. and Valonc, RH. (1991) "Tumor necrosis factor release by human monocytes stimulated with plateletactivating factor", Lipids 26, 1060-1064.
  • Poubelle, P.E., Gingras, D., Deniers, C., Dubois. C, Harbour, D., Gras.si, J and Rola-Pleszczynski. M. (1991) "Platelet-activating factor (PAF-acethcr) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-I by subsets of human monocytes", Immunology 72, 181-187.
  • Valone, F.H. (1991) "Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor", Journal of Allergy and Clinical Immunology 87, 715-720.
  • Gornez-Cambronerc, J., Durstin. M., Molski. T.F.P., Naccache, P.M. and Sha'afi, R.I (1989) "Calcium is necessary hut not sufficient for the platelet-activating factor release in human neutrophils stimulated by physiological stimuli", Journal of Biological Chemistry 264, 21699-21704.
  • Stafforini, D.M., Elstad, M.R., Mclntyre. T.M., Zimmerman. G.A. and Prescott. S.M. (1990) "Human macrophages secrete plateletactivating factor acctythydrolase", Journal of Biological Chemistry 265, 9682-9687.
  • Miwa, M., Miyake. T., Yauianaka. T., Sugatani. J., Suzuki. Y., Sakata. S., Araki, Y. and Matsurnoto, M. (1988) "Characterization of serum platelet-activating factor (PAF) acetythydrolase, Correlation between deficiency of serum PAF acetythydrolase and respiratory symptoms in asthmatic children", Journal of Clinical Investigations 82, 1983 -1991.
  • Stafforini, D.M., Prescott. S.M., Zunnierman. G.A. and Mclntyre. T.M. (1991) "Platelet-activating factor aceiylhydralase activity in human tissues and blood cells", Lipids 26, 979-985.
  • Stafforini, D.M., Pre-scott. S.M., Zimmcrman, GA. and Mclntyre. T.M. (1996) "Mammalian platelet-activating factor acctylhydrolascs", Biochimica el Biophysica Acta 1301, 161-173.
  • Salem, P., Deryckx, S., Dulioust. A., Vivier, E., Denizol. Y., Damais. C., Dinarello, C.A. and Thomas. Y. (1990) "Immunoregulatory functions of paf-acether. IV. Enhancement of IL-I production by muramyl dipeptide-stimulatcd monocytes", Journal of Immunutogy 144, 1338-1344.
  • Travers, J.B., Sprecher. H. and Fertel. R.H. (1990) 'The metabolism of platelet-activating factor in human T-lymphocytes", Biochimica et Biophysica Acta 1042, 193-197.
  • Triggiani, M., D'Souza. D.M. and Chilton. F.H. (1991) "Metabolism of l-acyl-2-aceiyl-sn-glycero-3-phosphocholinc in the human neutrophil", Journal of Biological Chemistry 266. 6928-6935.
  • lshii, S. and Shimizu, T. (2(100) "Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice", Progress in Lipid Research 39, 41-82.
  • Kotelevets, L., Noë. V., Bruyneel, E., Myssiakine, K., Chastrc, E., Marcel. M. and Gespath. C. (1998) "Inhibition by plateletactivating factor of SK- and hcpatocyle growth factor-dependent invasiveness of intestinal and kidney epithelial cells", Journal of Biological Chemistry 273, 14138-14145.
  • Youlyouz, I., Magnoux. M., Guglielmi L. and Denizot, Y. (2002) "Expression of a splice variant of the PAf receptor transcript 2 in various human cancer cell lines", Mediators of Inflammation 11, 329-331.
  • Izumi, T., Honda. Z.,I., Mutoh. H., Kume, K., Shimizu. T., et al. (1995) "Regulation and signal transduction of PAK receptor", In: Samuelsson. B., ed, Advances in Prostaglandins, Thromboxane and Leukotriene Research (Raven Press. Ltd., New York) 23. pp. 461-466.
  • Shukla, S.D. (1992) "Platelet-activaring factor receptor and signal transduction mechanisms", FASEB Journal 6, 2296-2301.
  • Jouvin-Marche, E., Ninio. E., Beaurain. G., Tencé. M., Niaudel. P. and Benveniste. J. (1984) "Biosynthesis of paf-acether (plateletactivating factor). VIl. Precursors of paf-acether and acctyltransferase activity in human leukocytes", Journal of Immunology 133. 892-898.
  • Foa, R., Bussolino. F, Fetrando. M.L., Guarini, A., Tetta. C., Mazzone. R., Gugliotta. I., and Camussi. G. (1985) "Release of platelet-activating factor in human leukemia", Cancer Research 45, 4483 -4485.
  • Desplat, V., Dulery. C., Faucher. J.L., Praloran, V. and Denizot, Y. (2000) "Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines", Cancer Letters 149. 7-13.
  • Nguer, CM., Pellegrini. O., Galanaud. P., Benveniste. J., Thomas. Y. and Richard. Y. (1992) "Regulation of paf-acether receptor expression in human B cells", Journal of Immunology 149. 2742- 2748.
  • Nguer, CM., Treton. D., Rola-Pleszczynski. M., Mishal. Z., Thomas. U., Galanaud. P. and Richard. Y. (1996) "Regulation of platelet-activating factor receptor expression in human B cells and B cell lines", Lipids 31, 1051-1058.
  • Bastient, Y., Toledano. B.J., Mehio. N., Cameron. L., Lamoukhaid. B., Renzi. P., Hamid. Q and Mazer. B.D. (1999) "Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes", Journal of Immunology 162. 5498-5505.
  • Travers, J.B., U, Q., Kniss. D.A. and Fertel. R.H. (1989) "Identification of functional platelet-activating factor receptors in raji Iymphoblasts", Journal of Immunutagy 143, 3708-3713.
  • Yang, H.H., Pang. J.H., Hung. R.Y. and Chau. L.Y. (1997) "Transcriptioiial regulation of platelet-activating factor receptor gene in B lymphoblastoid ramos cells by TGF-ß", Journal of Immtmulagy' 158, 2771-2778.
  • Zhuang, Q., Bastien. Y. and Mazer, B.D. (2000) "Activation via multiple signalling pathways induces down-regulation of plateletactivating factor receptors on human B lymphocytes", Journal of Immunology 165, 2423-2431.
  • Quellet, S., Muller, E. and Rola-Pleszczynski. M. (1994) "INFgamma up-regulates platelet-activating factor receptor gene expression in human raonocytcs", Journal of Immunology 152. 5092-5099.
  • Smith, C.S., Parker. I., and Shearer. W.T. (1994) "Cytokine regulation by platelet-activating factor in a human B cell line", Journal of Immunology 153, 3997- 4005.
  • Franklin, R.A., Mazer. B., Sawami. H., Mills. G.B., Terada. N. Lucas. J.J. and Gelfand. E.W (1993) "Platelet-activating factor triggers the phosphorylatitin and activation of MAP-2 kinase and S6 peptide kinase activity in human B cell lines", Journal of lmmunoloKy 151, 1802-1810.
  • Schulam, PG., Kuruvilla. A., Pulcha. G., Mangus. L., Franklin-Johnson. J. and Shearer. W.T. (1991) "Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation and oncogene expression in a human B cell line", Journal of Immunology 146. 1642-1648.
  • Franklin, R.A., Tordai. A., Mazer. B., Terada. N., Lucas, J. and Gelfarxl. L.W. (1995) "Platelet-activating factor activate* MAPK and increases in inlracellular calcium via independent pathways inB lymphocytes", Biochemical and Biophysical Research Communications 209, 1111-1118.
  • Kuruvilla, A., Pielop. C. and Shearer. WT. (1994) "Plateletactivating factor induces the tyrosine phosphorylation and activation of poospholipase C-gl. Fyn and Lyn kinases, and phosphatidylinositol 3-kinase in a human B cell line", Journal of Immunology 153, 5433-5442.
  • Leprince, C., Vivier, E., Treton. D., Galanaud. P., Benveniste. J., Richard, Y. and Thomas, Y. (1991) "Iminimoregulalory functions of paf-acether. Vl. Dual effect on human B cell proliferation", Lipids 26, 1204-1208.
  • Travers, J.B., Li. Q., Sprecher, H. and Fend. R.H. (1992) "Binding of carbamyl-platelet-activatinp factor to the Raji lymphoblast platelet-activating factor receptor", International Journal of Immunopharmarology 14, 515-523
  • Rosskopf, D., Hartung, K. Hense. J. and Siffert, W. (1995) "Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients", Hypertention 26, 432-435.
  • Mazer, B., Clay. K.L., Renz, H. and Gelfand. E.W. (1990) "Plateletactivaiing factor enhances Ig production in B lymphoblasioid cell lines", Journal of Immunology 145, 2602-2607.
  • Mazer, B.D., Sawami. H., Franklin, R. and Gelfand. E.W. (1991) "B-cell activation and regulation of immunoglobulin synthesis by platelet-activating factor", Netherlands Journal of Medicine 39. 244-253.
  • Smith, C.S. and Shearer. W.T. (1994) "Activation of NF-êA and immunoglohulin expression in response to plateletactivating factor in a human B cell line", Cellular Immunology 155, 292-303.
  • Deryckx, S., De Waal Malefyi. R., Gauchal. J.F., Vivier, t., Thomas. Y. and De V ries, J.B. (1992) "lmmunoregulatory functions of paf-acether. VIIl. Inhibition of II.-4-induced human IgE synthesis in vitro", Journal of Immunology 148, 1465-1470.
  • Denizol, Y, Trimoreau, F. Dupuis, F. Verger. C. and Praloran. V. (1995) "PAF and haematopoiesis. III. Presence and metabolism of platelet-activating factor in human bone marrow. Biochemica et Biophysica Acta 1265, 55-60.
  • Dupuis, F., Rougier. F., Trimoreau. F. Ostyn. h., Dulery, C., Praloran. V. and Deoizot, Y. (1997) "Production and metabolism of platelet-activating factor by human bone marrow cells", Research in Immunology 148, 119-126.
  • Denizot, Y., Rougier. F., Dupuis, F. Verger. C., Dulery. C., Laskar, M., Aldigier, J C. and Praloran. V. (1996) "PAF and haematopoiesis. Vu!. Biosynthesis and metabolism of platelet-activating factor by human bone marrow stromal cells", Experimental Hematology 24. 1327-1332.
  • Desplat, V., Besse, A., Haucher. J.L., Praloran. V. and Denizot. Y (1997) "Expression of platelet-activating factor receptor transcript1 but not transcript-2 by human bone marrow cells", Stem Cells 17, 121-477.
  • Desplat, V., Faucher, J.L., Mahon, F.X., Sbarha. P.D., Praloran, V. and Ivanovic, J. (2002) "Hypoxia modifies proliferation and differentiation of CD34 + CML cells", Stem Cells 20, 347-354.
  • Dupuis, F., Gachard, N, Allegraui A., Dulery. C., Praloran. V. and Denizot, Y. (1998) "Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors", Mediators of Inflammation 7, 99-103.
  • Rougier, F, Dupuis, E. Comu. E., Dulery. C"., Praloran, V. and Denizot. Y. (1997) "Platelet-activating factor and antagonists modulate DNA synthesis in human hone marrow stromal cell cultures", Journal of Lipid Mediators and Cell Signalling 16, 147-153.
  • Saito, H., Hayakawa. T., Mita. H., Akivama. K. and Shida. T. (1992) "PAF-induced eosinophilic and basophilic differentiation in human heraatopoietic precursor cells", Journal of Lipid Mediators 5. 135-137.
  • Saito, H., Koshio, T., Yanagihara. Y., Akivama, K. and Shida, T (1993) "Platelet-activating-factor-induced augmentation of production of eosinophil-lineage cells in hematopoietic precursor cells obtained from human umbilical cord blood", International Archives of Allergy and Immunology 102, 375-382.
  • Fixe, P., Rougier, F. Ostyn. F.,. Gachard. N., Faucher. J.L., Pralorun. V. and Denizot. Y. (1997) "Spontaneous and inducible production of macrophage-colony stimulating factor by human bone marrow siromal cells", European Cytokine Network 8, 91-95.
  • Bellone, G., Astarita, P., Artusio, E., Silvestri, S., Mareschi. K., Turletti, A., Buttiglieri. S., Emanuelli, G. and Matera. L. (1997)"Bone marrow stroma-derived prolactin is involved in basal and platelet-activating factor-stimulated in vitro erythropoiesis", Blood 90, 21-27.
  • Denizot, Y. Raher. S., Trimoreau. F, Praloran. V. and Godard. A. (2000) "Effect of cytokines and lipid mediators on the synthesis of interleukin Iß by human bone marrow strornal cells", Cftokine 12. 499- 502.
  • Denizot, Y., Godard, A., Raher. S., Trimoreau. II. and Praloran, V. (1999) "Lipid mediators modulate the synthesis of interleukin 8 by human bone marrow stromal cells", Cytokine 11, 606-610.
  • Denizot, Y., Trimoreau. E and Praloran. V. (1998) "Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells", Ctokine 10. 781-785.
  • Denizot, Y., Rougier, E. Cornu, E. and Praloran. V. (1996) "Plateletactivating factor and haematopoiesis. XI. Platelet-activating factor has no effect on the production of interIeukin-6 and tumor necrosis faclor-á by human bone marrow stromal cells", European CytokineNetwork 7, 75-77.
  • Denizot, Y., Dupuis, F, Trimoreau, E, Praloran, V and Liozon. E. (1995) "Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies", Blood 85, 2992-2993.
  • Denizot, Y., Trimoreau. E. Dupuis, E. Verger, C. and Praloran. V. (1995) "Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid malignancies", Leukemia 9. 1982 1983.
  • Houlihan, W.J., Lohmeyer, M., Workman. P. and Cheon, S.U. (1995) "Phospholipid antitumor agents", Medicine Research Review 15, 157-223.
  • Schick, H.D., Berdel. W.E., Fromm. M., Fink. L., UIm. K., Reichert. A., Eibl. H., Unger. C. and Rasletter, J. (1987) "Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro", Lipids 22. 904-910.
  • Sawyer, D.B. and Andersen, O.S. (1989) "Platelet-activating factor is a general membrane perturbant", Biochimica et Biophysica Acta 987, 129-132.
  • Doonard, M., Guglielmi, L, Piguet, C., Couraud, Vl.J., Bordessoule. D. and Demzot. Y. (2002) "Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia", Stem Cells 20, 394-401.
  • Trimoreau, F., Guglielrai. L., Touati, M., Faucher. J.L., Bordessoule, D. and Denizot. Y. (2001) "Platelet-activating factor receptors on B cells of chronic Iymphocytic leukaemia patiens", British Journal of Haematology 115, 711-712.
  • Vincent, J.L., Spapen, H., Bakker. J., Websier, N.R. and Curtis, L. (2000) "Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis", Critical Cure Medicine 28, 638-642.
  • Supultamongkol, Y. lntaranongpai, S., Smith, M.D., Angus. B., Chaowagul, W., Permpikul. C., Simpson, J.A., Leelarasamee. A., Curtis. L and While. N.J. (2000) "A double-blind placebocontrolled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis", Antimicrobial Agents and Chemotherapy' 44. 693-696.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.